S. R. Schill & Associates Danaher Corp Transaction History

S. R. Schill & Associates

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$235.51 - $267.98 $7,065 - $8,039	30 Added 2.79%	1,106 $276,000
Q1 2024 Apr 04, 2024	BUY	$224.58 - $256.19 $13,923 - $15,883	62 Added 6.11%	1,076 $268,000
Q4 2022 Jan 25, 2023	SELL	$241.42 - $282.29 $14,485 - $16,937	-60 Reduced 5.59%	1,014 $0
Q2 2022 Aug 31, 2022	SELL	$237.11 - $299.66 $78,957 - $99,786	-333 Reduced 23.67%	1,074 $272,000
Q3 2021 Oct 25, 2021	SELL	$272.21 - $332.43 $46,275 - $56,513	-170 Reduced 10.78%	1,407 $428,000
Q2 2021 Aug 17, 2021	SELL	$225.08 - $271.69 $5,627 - $6,792	-25 Reduced 1.56%	1,577 $423,000
Q1 2021 Apr 30, 2021	SELL	$212.38 - $245.9 $2,548 - $2,950	-12 Reduced 0.74%	1,602 $361,000
Q3 2020 Nov 18, 2020	BUY	$177.16 - $215.33 $30,117 - $36,606	170 Added 11.77%	1,614 $348,000
Q2 2020 Jul 30, 2020	BUY	$128.7 - $176.83 $185,842 - $255,342	1,444 New	1,444 $255,000
Q1 2020 May 04, 2020	SELL	$121.39 - $169.05 $175,287 - $244,108	-1,444 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$133.47 - $153.48 $2,669 - $3,069	-20 Reduced 1.37%	1,444 $222,000
Q3 2019 Oct 24, 2019	BUY	$135.4 - $146.47 $135 - $146	1 Added 0.07%	1,464 $211,000
Q2 2019 Aug 19, 2019	SELL	$124.88 - $143.73 $218,165 - $251,096	-1,747 Reduced 54.42%	1,463 $209,000
Q1 2019 May 02, 2019	SELL	$97.62 - $132.29 $60,329 - $81,755	-618 Reduced 16.14%	3,210 $424,000
Q4 2018 Jan 24, 2019	BUY	$94.85 - $109.54 $166,936 - $192,790	1,760 Added 85.11%	3,828 $395,000
Q3 2018 Oct 30, 2018	BUY	$98.13 - $108.9 $202,932 - $225,205	2,068 New	2,068 $225,000

2,510

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $173B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of S. R. Schill & Associates, based on Form 13F filings with the SEC.

Stay updated on S. R. Schill & Associates with notifications on news.